BiotechTube
Home/Grifols/Jordi Ramentol
JR

Jordi Ramentol

Chief Operating Officer (COO) - Biopharma Business Unit

Grifols

Therapeutic Areas

ImmunologyHematologyHepatologyIntensive CarePulmonologyNeurologyInfectious Diseases

Grifols Pipeline

DrugIndicationPhase
Subcutaneous Immunoglobulin (SCIG)Primary & Secondary ImmunodeficienciesMarketed
Alpha-1 Antitrypsin (AAT)Alpha-1 Antitrypsin Deficiency (AATD)Marketed
CHRONOS-PD PlatformParkinson's DiseaseResearch
Next-Generation Coagulation FactorsHemophilia A & BDevelopment

Leadership Team at Grifols

TG
Thomas Glanzmann
Executive Chairman of the Board
RG
Raimon Grífols Roura
Co-CEO and Executive Vice-Chairman
VG
Victor Grífols Deu
Co-CEO
AA
Alfredo Arroyo
Chief Financial Officer (CFO)
SG
Sílvia Grífols
Board Member
NP
Nuria Pascual
Board Member
View full Grifols profile